Document is current
Any future updates will be listed below
-
Authors
Ghosh, Anjuli https://orcid.org/0009-0006-9138-0177
Nasarre-Nacenta, Natalia
Baumeister, Sarah https://orcid.org/0000-0001-9005-0084
Holz, Nathalie E. https://orcid.org/0000-0002-6225-9267
Banaschewski, Tobias https://orcid.org/0000-0003-4595-1144
Brandeis, Daniel
Aggensteiner, Pascal-M. https://orcid.org/0000-0002-1048-9044
Kaiser, Anna https://orcid.org/0009-0001-6373-8278
-
Funding
Funding for this research was provided by:
Medizinische Fakultät Mannheim der Universität Heidelberg
- License Information
-
More Information
Article History
Received: 25 July 2025
Accepted: 1 November 2025
First Online: 22 November 2025
Change Date: 2 January 2026
Change Type: Update
Change Details: The original online version of this article was revised: due to the equal contribution section is missing in the article.
Declarations
:
: The author Tobias Banaschewski served in an advisory or consultancy role for eye level, Infectopharm, Medice, Neurim Pharmaceuticals, Oberberg GmbH and Takeda. He received conference support or speaker’s fee by Janssen-Cilag, Medice and Takeda. The author Daniel Brandais served as an unpaid scientific advisor for an EU-funded neurofeedback trial. However, these fundings and affiliations had no influence on the design, execution, or interpretation of this research work. All other authors declare no conflicts of interest.
